Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morie A Gertz

Showing results (1-10 of 754) with videos related to

Pageof 76
Sort By:
Mayo Clinic Proceedings|December 14, 2002
Diagnosing primary amyloidosisMorie A Gertz
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2015
Using Novel Agents and Stem Cell Transplantation to Optimally Manage Immunoglobulin Light Chain AmyloidosisMorie A Gertz
Leukemia & Lymphoma|November 12, 2010
Waldenström macroglobulinemia: is newer really better?Morie A Gertz
Leukemia & Lymphoma|May 21, 2015
When to recommend allogeneic transplant in multiple myelomaMorie A Gertz
The Lancet. Haematology|November 16, 2016
Panobinostat in multiple myelomaMorie A Gertz
Leukemia & Lymphoma|September 11, 2019
Management of induction failures in newly diagnosed transplant-eligible multiple myelomaMorie A Gertz
Journal of the American College of Cardiology|July 20, 2019
Therapy of Transthyretin CardiomyopathyMorie A Gertz
Haematologica|April 6, 2006
Cold agglutinin diseaseMorie A Gertz
American Journal of Hematology|June 2, 2005
Waldenström macroglobulinemia: a review of therapyMorie A Gertz
Mayo Clinic Proceedings|July 14, 2006
Autologous attack on amyloidosisMorie A Gertz
Pageof 76

Showing results (1-10 of 754) with videos related to

Sort By:
Pageof 76
Mayo Clinic Proceedings|December 14, 2002
Diagnosing primary amyloidosisMorie A Gertz
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2015
Using Novel Agents and Stem Cell Transplantation to Optimally Manage Immunoglobulin Light Chain AmyloidosisMorie A Gertz
Leukemia & Lymphoma|November 12, 2010
Waldenström macroglobulinemia: is newer really better?Morie A Gertz
Leukemia & Lymphoma|May 21, 2015
When to recommend allogeneic transplant in multiple myelomaMorie A Gertz
The Lancet. Haematology|November 16, 2016
Panobinostat in multiple myelomaMorie A Gertz
Leukemia & Lymphoma|September 11, 2019
Management of induction failures in newly diagnosed transplant-eligible multiple myelomaMorie A Gertz
Journal of the American College of Cardiology|July 20, 2019
Therapy of Transthyretin CardiomyopathyMorie A Gertz
Haematologica|April 6, 2006
Cold agglutinin diseaseMorie A Gertz
American Journal of Hematology|June 2, 2005
Waldenström macroglobulinemia: a review of therapyMorie A Gertz
Mayo Clinic Proceedings|July 14, 2006
Autologous attack on amyloidosisMorie A Gertz
Pageof 76